Chugai Pharmaceutical Co., Ltd.
CHGCF
$42.03
-$1.06-2.45%
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.94B | 6.25B | 7.12B | 6.31B | 5.05B |
| Total Receivables | 2.36B | 2.83B | 2.20B | 1.97B | 1.59B |
| Inventory | 1.96B | 1.77B | 1.63B | 1.56B | 1.83B |
| Prepaid Expenses | -- | 158.53M | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 260.19M | 103.62M | 273.36M | 292.35M | 262.38M |
| Total Current Assets | 10.52B | 11.10B | 11.23B | 10.13B | 8.74B |
|
|
|||||
| Total Current Assets | 10.52B | 11.10B | 11.23B | 10.13B | 8.74B |
| Net Property, Plant & Equipment | 3.11B | 3.06B | 3.27B | 3.10B | 2.82B |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 366.05M | 347.85M | 230.75M | 115.66M | 129.31M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 522.97M | 563.21M | 499.18M | 949.29M | 426.45M |
| Total Assets | 15.13B | 15.74B | 15.79B | 14.29B | 12.55B |
|
|
|||||
| Total Accounts Payable | 992.37M | 811.59M | 543.52M | 471.37M | 586.56M |
| Total Accrued Expenses | -- | 341.81M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 49.58M | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.43B | 1.42B | 1.32B | 920.50M | 993.43M |
| Total Other Current Liabilities | 1.43B | 1.42B | 1.32B | 920.50M | 993.43M |
| Total Current Liabilities | 2.42B | 2.62B | 1.86B | 1.39B | 1.58B |
|
|
|||||
| Total Current Liabilities | 2.42B | 2.62B | 1.86B | 1.39B | 1.58B |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 114.40M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 185.64M | 88.33M | 172.89M | 159.14M | 110.65M |
| Total Liabilities | 2.61B | 2.82B | 2.03B | 1.55B | 1.69B |
|
|
|||||
| Common Stock & APIC | 865.16M | 916.63M | 994.43M | 957.23M | 943.59M |
| Retained Earnings | 11.61B | 12.05B | 12.81B | 11.69B | 9.90B |
| Treasury Stock & Other | 47.42M | -51.20M | -40.64M | 90.26M | 13.21M |
| Total Common Equity | 12.52B | 12.92B | 13.76B | 12.74B | 10.86B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.52B | 12.92B | 13.76B | 12.74B | 10.86B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.52B | 12.92B | 13.76B | 12.74B | 10.86B |
|
|
|||||